Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015
Go back to Sanofi and Regeneron to Present Results from Phase 3 Praluent® (alirocumab) Injection Clinical Trials at AHA Scientific Sessions 2015| Regeneron (NASDAQ: REGN) | Delayed: 620.14 -3.29 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $623.43 | 52 Week High | $592.36 | |||
| Open | $623.16 | 52 Week Low | $325.35 | |||
| Day High | $634.31 | P/E | 162.77 | |||
| Day Low | $619.70 | EPS | $3.81 | |||
| Volume | 696,860 | |||||
| BANCO SANTANDER S.A. (NYSE: SAN) | Delayed: 13.38 +0.01 (0.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.37 | 52 Week High | $5.58 | |||
| Open | $13.41 | 52 Week Low | $3.60 | |||
| Day High | $13.54 | P/E | N/A | |||
| Day Low | $13.35 | EPS | $0.00 | |||
| Volume | 6,341,481 | |||||
| SANOFI (NASDAQ: SNY) | Delayed: 41.80 +0.47 (1.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.33 | 52 Week High | $44.76 | |||
| Open | $41.50 | 52 Week Low | $36.81 | |||
| Day High | $42.14 | P/E | N/A | |||
| Day Low | $41.42 | EPS | $0.00 | |||
| Volume | 4,522,657 | |||||
